9 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... Guideline for the Management ... Task Force on Clinical ... #HeartFailure #Management ... #treatment #algorithm
Boxer's Fracture - ED Management
Be sure to assess for wounds in patients with fractures of the
prophylactic antibiotic treatment ... hematoma block or ulnar ... object) • Splint: Ulnar ... Thumb #Metacarpal #Radiology ... #Orthopedics #MSK
Single Syringe Adenosine - Instructions
1) Dilute 6-12 mg of adenosine in a syringe for a total
patient's arm Clinical ... to place IV in AC ... #Instructions #pharmacology ... #SVT #cardiology ... #management
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... recommended by the ACC ... HeartFailure #HFrEF #Pharmacology ... #Management #Treatment ... #StageC #Cardiology
Myocarditis 

5 Principles of
Myocarditis:
1. Build clinical suspicion
2. Decide on EMBx
3. Manage acute cardiac injury
4. Manage chronic
Build clinical suspicion ... Low voltage Treatment ... agent, steroids, AC ... Myocarditis #diagnosis #management ... #cardiology #summary
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
Fraction (HFrEF) Clinical ... Other: Electrocardiogram ... endomyocardial biopsy Pharmacology ... heartfailure #diagnosis #management ... #cardiology #pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
& Dry) is the treatment ... & Dry” is the treatment ... differential #algorithm #management ... #cardiology #treatment ... #pharmacology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
specific questions to ask ... Change in clinical ... indication of AC ... one post op Cardiology ... medical and surgical management
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
salivary ducts Clinical ... phenomenon (16%) MSK ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management